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Abstract
Bone morphogenetic protein-2 (BMP-2), is a potential factor to enhance osseointegration of dental implants. However, the 
appropriate cellular system to investigate the osteogenic effect of BMP-2 in vitro in a standardized manner still needs to be 
defined. The aim of this study was to examine the effect of BMP-2 on the cell proliferation and osteogenic differentiation of 
human osteogenic progenitors of various origins: dental pulp stem cells (DPSC), human osteosarcoma cell line (Saos-2) and 
human embryonic palatal mesenchymal cell line (HEPM). For induction of osteogenic differentiation, cell culture medium 
was supplemented with BMP-2 homodimer alone or in combination with conventionally used differentiation inducing agents. 
Differentiation was monitored for 6–18 days. To assess differentiation, proliferation rate, alkaline phosphatase activity, 
calcium deposition and the expression level of osteogenic differentiation marker genes (Runx2, BMP-2) were measured. 
BMP-2 inhibited cell proliferation in a concentration and time-dependent manner. In a concentration which caused maximal 
cell proliferation, BMP-2 did not induce osteogenic differentiation in any of the tested systems. However, it had a synergistic 
effect with the osteoinductive medium in both DPSC and Saos-2, but not in HEPM cells. We also found that the differentia-
tion process was faster in Saos-2 than in DPSCs. Osteogenic differentiation could not be induced in the osteoblast progenitor 
HEPM cells. Our data suggest that in a concentration that inhibits proliferation the differentiation inducing effect of BMP-2 
is evident only in the presence of permissive osteoinductive components. β-glycerophosphate, was identified interacting 
with BMP-2 in a synergistic manner.
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Introduction
One of the most important issues in dental implantology is 
to conduce osteogenic integration of dental implants by the 
modification of titanium surface. Many efforts have been 
made aiming to enhance cell adhesion and bone formation 
by several molecules linked to titanium. Different bioactive 
organic macromolecules could be suitable for modification 
of the surface of dental implants such as BMP-2 and BMP-7 
approved by the American Food and Drug Administration 
(FDA) to use in the clinical practice: [1]. To reproducibly 
test the osteogenic effects of such compounds, reliable 
in vitro test systems are needed.
In the present study, the BMP-2 homodimer protein was 
selected to use, which is known to initiate osteogenic dif-
ferentiation and bone formation both in vitro [2–4] and 
in vivo [2, 4, 5]. BMP-2 belongs to the BMP subgroup of the 
transforming growth factor-β (TGF-β) protein superfamily 
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involved in the regulation of multiple organogenic develop-
mental processes including bone formation and skeletogen-
esis [6, 7]. In a comparative analysis, 14 members of the 
BMP protein family were studied to identify factors with the 
most potent osteoinductive activity. It turned out that BMP-
2, BMP-6 and BMP-9 showed the most potent osteogenic 
activity [8]. The functional form of BMP-2 is a homodi-
mer which is the ligand of the cell surface BMP receptors 
(BMPRI, BMPRII). Binding of the BMP-2 homodimer acti-
vates intracellular signal transduction through the SMAD or 
MAPK pathways [9] which can interact with other signaling 
pathways through FGF, Hedgehog and Wnt proteins regulat-
ing the expression of several transcription factors such as 
Sox 9, Cbfa1 (Runx2) and Msx [10] involved in osteogenic 
differentiation and bone formation.
Here we report a comparative study investigating the 
effect of recombinant BMP-2 homodimer proteins on 
osteogenic differentiation of human dental pulp stem cells 
(DPSC) isolated from the pulp tissue of healthy human wis-
dom teeth and two commonly used preosteoblast cell lines, 
namely Saos-2 osteosarcoma cells and human embryonic 
palatal mesenchymal preosteoblast cells (HEPM). Most 
studies investigating the effect of BMP-2 involve only one 
cell type. In contrast to the shortcomings due to the appli-
cation of a single cell type, multiple cell types offer more 
precise and valid analysis. Published data have shown that 
the effect of BMP-2 depends both on the environment and 
the cell type [11]. Furthermore, the effect of BMP-2 on 
DPSCs has been poorly studied. Therefore, our aim was to 
determine the effective concentration of BMP-2, to study 
its effect on DPSCs in comparison with two other cell lines, 
commonly used in osteogenic differentiation experiments 
and to analyze BMP-2 applied alone and in different molecu-
lar environments containing agents conventionally used to 
induce osteogenic differentiation.
Materials and methods
Cell growth and osteogenic differentiation
Human dental pulp stem cells (DPSCs) were isolated from 
the pulp tissue of healthy human wisdom teeth as it was 
described previously [12], and were sorted for STRO-1 cell 
surface marker [13] (patient declaration of agreement No. 
F0102/1ST). Human embryonic palatal mesenchymal cells 
(HEPM, ATCC No.: CRL-1486) Saos-2 osteosarcoma cells 
(ATCC No.: HTB-85) and STRO-1 positive DPSCs were 
cultured in Eagle’s Minimum Essential Medium (EMEM, 
Sigma Aldrich, M5650), Dulbecco’s Modified Eagle’s 
Medium (DMEM, Sigma Aldrich, D6046) and Alpha modi-
fied Minimum Essential Medium (αMEM, Sigma Aldrich, 
M4526), respectively, supplemented with 10% FBS (Sigma 
Aldrich, F9665), 100 units/ml penicillin and 100 mg/ml 
streptomycin (Sigma Aldrich, P0781), and 1% GlutaMAX 
(Life technologies, 10567014) at 37 °C, 5%  CO2 in a humidi-
fied atmosphere. These culture media are further indicated 
on the figures and in the text as control media (CM).
Osteoinductive medium (OIM) was prepared by sup-
plementing CM with 10 mM β-glycerophosphate (Sigma 
Aldrich, G9891), 50 µg/ml ascorbic acid (Sigma Aldrich, 
1043003), 0.1 µM dexamethasone (Sigma Aldrich, D4902) 
and 50 nM vitamin D3 (Sigma Aldrich, 740292).
Media indicated on the figures as β-GLY, AA, DEX and 
D3 VIT were prepared by supplementing CM with 10 mM 
β-glycerophosphate (β-GLY), 50 µg/ml ascorbic acid (AA), 
0.1 µM dexamethasone (DEX) or 50 nM vitamin D3 (D3 
VIT), respectively.
Media indicated on the figures as CM  +  BMP-2, 
OIM + BMP-2 and β-GLY + BMP-2 were prepared by 
supplementing CM, OIM and β-GLY media with BMP-2 
(Antibodies-online GmbH, Z00327) in a final concentration 
of 0.1 µg/ml.
BMP-2 stock solution was prepared from lyophilized 
recombinant human BMP-2 according to manufacturer’s 
instructions in a final concentration of 1 mg/ml and aliquots 
were stored at − 80 °C until use.
Alamar blue assay
Into each well of a 96 well cell culture plate (VWR, 89093-
608), 1000 cells in the case of HEPM and Saos-2 and 7000 
cells in the case of DPSC were seeded in 200 µl CM. Cells 
were allowed to attach overnight, then CM was removed 
(day 0), cells were washed with 200 µl colourless DMEM 
(Sigma Aldrich, D5921) and were incubated in 200  µl 
alamar blue reagent (Life Technologies, DAL 1100) diluted 
1:10 in colourless DMEM. Incubation was for 3 h in the case 
of HEPM and Saos-2 cells and 2 h in the case of DPSC at 
37 °C in 5%  CO2. Alamar blue assay was previously opti-
mized for each cell type (data not shown). After incubation, 
fluorescence of the reduced alamar blue was measured by 
Hidex Sense Microplate reader using 535 nm excitation light 
and 595 nm emission filter. After the measurement, alamar 
blue was changed to the appropriate media (Figs. 1, 2) and 
culturing was countinued. Measurements were repeated at 
every second day during an 8-day long interval. Fluores-
cence intensities were normalized to the fluorescence meas-
ured at day 0.
Measurement of calcium deposition
Into each well of a 6 well cell culture plate, 300,000 cells 
were seeded in 2 ml CM. Cells were allowed to attach 
overnight, then culture medium was changed (day 0) to 
the appropriate media involved in the experiments (see 
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Figs. 3, 4). Media were changed every second day. After 
6, 12 or 18 days media were removed, cells were washed 
two times with 2 ml 1 × PBS (Sigma Aldrich, P5493) 
and were dehydrated with 2 ml ice cold methanol (Sigma 
Aldrich, 322415) for 30 min. After removal of the metha-
nol, samples were dried out for 5 min at room temperature 
and were stained with 2% (w/v) Alizarin Red S solution 
(Sigma Aldrich, A5533) adjusted to pH 4.27 in the case 
of HEPM and Saos-2 cells or adjusted to pH 7 in the case 
of DPSC (Alizarin Red S adjusted to pH 4.27 did not 
stain DPSCs nicely). For quantification of the staining, 
Alizarin Red S—calcium complexes were extracted with 
10% cetylpyridinium chloride (Sigma Aldrich, C0732) 
diluted in 10 mM sodium phosphate buffer adjusted to 
pH 7 (Sigma Aldrich, P5244) and absorbance was meas-
ured by a Hidex Sense Microplate reader at 570 nm. For 
standardization, protein concentration of cell lysates was 
determined with Pierce BCA Protein Assay (Thermo 
Scientific, 23227) (according to instruction provided by 
manufacturer) from parallel samples that were not stained 
with Alizarin Red S. Quantified calcium deposition was 
expressed as  A570nm/µg protein.
Fig. 1  Measurements of cell proliferation by alamar blue assay. 
DPSC (a), Saos-2 (b) and HEPM (c) cells were examined in control 
medium (CM) supplemented with different concentrations of BMP-2. 
Experiments were carried out using OIM medium supplemented with 
the same concentration series of BMP-2 on DPSC (d), Saos-2 (e) and 
HEPM (f) cells. Error bars represent standard deviation calculated 
from three parallel measurements. Statistical analysis was performed 
using ANOVA followed by Bonferroni statistical test. P < 0.05 and 
P < 0.005 values were labeled on the figure as “*” and “**”, respec-
tively
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Alkaline phosphatase (ALP) activity
Into each well of a 6 well cell culture plate, 300,000 cells 
were seeded in 2 ml CM. Cells were allowed to adhere 
overnight, then culture medium was changed (day 0) to 
the appropriate media involved in the experiments (Figs. 3, 
4). Media were changed every second day. After 6, 12 or 
18 days, media were removed and cells were washed two 
Fig. 2  Measurements of cell proliferation by alamar blue assay 
on DPSC (a), Saos-2 (b) and HEPM (c) cells cultured in control 
medium (CM) supplemented with different components of the OIM 
medium such as: ascorbic acid (AA), β-glycerophosphate (β-GLY), 
dexamethasone (DEX), vitamin D3 (D3 VIT). Those components 
which decreased proliferation (β-glycerophosphate and dexametha-
sone) were combined with BMP-2 and were examined on DPSC (d), 
Saos-2 (e) and HEPM (f) cells. Error bars represent standard devia-
tion calculated from three parallel measurements. Statistical analysis 
was performed using ANOVA followed by Bonferroni statistical test. 
P < 0.05 or P < 0.005 values were labeled on the figure as “*” and 
“**”, respectively
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times with 2 ml 1 × PBS. Cells were lysed in lysis buffer 
[10 mM Tris–HCl pH: 7.4, 100 mM NaCl, 1 mM EDTA, 
1% Triton X-100, 1% protease inhibitor cocktail (PIC), 1% 
phenylmethylsulfonyl fluoride (PMSF)] and scraped lysate 
was transferred into Eppendorf tubes. After centrifugation 
(10,000g, 10 min, 4 °C), the supernatant was used for the 
determination of enzyme activity as well as protein con-
centration (Pierce BCA Protein Assay, Thermo Scientific, 
23227). Measurement of alkaline phosphatase activity 
was conducted 6 min after mixing cell lysates with the 
enzyme–substrate, 0.1% p-nitrophenyl phosphate (Sigma 
Aldrich, N7653; in 0.1 M glycine, 1 mM  MgCl2,  ZnCl2, 
pH 10.4) at 405 nm by a Hidex Sense Microplate reader. 
ALP activity was normalized to protein concentration and 
expressed as  A405nm/µg protein.
Total RNA extraction, reverse transcription, 
and real‑time PCR analysis
Into each well of a 6 well cell culture plate, 300,000 cells 
were seeded in 2 ml CM. Cells were attached overnight, 
then culture medium was changed (day 0) to the appro-
priate media involved in the experiments (Fig. 5). Media 
were changed every second day. After 4 days in the case 
of Saos-2 or after 6, 12 or 18 days in the case of DPSCs 
media were removed and cells were washed two times 
with 2 ml 1 × PBS. Cell lysis, total RNA extraction, real-
time quantitative PCR and calculation of relative expres-
sions were performed as described: [14]. Expression 
levels of the genes analyzed [TaqMan gene expression 
assays: Runx2 (Applied Biosystems, Hs00231692_m1), 
Fig. 3  Mineralization of DPSC (a) Saos-2 (d), and HEPM (g) cells 
were visualized by Alizarin Red S staining at the 6th day of differen-
tiation. Calcium bound dye was extracted and quantitatively analyzed 
by spectrofluorimeter in DPSC (b) Saos-2 (e), and HEPM (h) cells. 
From parallel samples alkaline phosphatase activity was also meas-
ured in DPSC (c) Saos-2 (f), and HEPM (i) cells. Error bars represent 
standard deviation calculated from three parallel measurements. Sta-
tistical analysis was performed using ANOVA followed by Bonfer-
roni statistical test. P < 0.05 or P < 0.005 values were labeled on the 
figures as “*” and “**”, respectively
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BMP-2 (Applied Biosystems, Hs00154192_m1)] were 
normalized to the reference house keeping gene GAPDH 
(glycerol-aldehyde-3-phosphate dehydrogenase) in each 
sample.
Statistical analysis
Error bars on the figures represent the standard deviation 
calculated from three parallel measurements. Statistical 
analysis was performed using ANOVA, Bonferroni sta-
tistical test. P < 0.05 or P < 0.005 values were labeled on 
the figures as “*” and “**”, respectively.
Results
BMP‑2 inhibits cell proliferation
The effect of BMP-2 on cell proliferation was studied for 
8 days on DPSC, Saos-2 and HEPM cells treated with a 
concentration series of BMP-2 diluted in CM (Fig. 1a–c) 
or in OIM (Fig. 1d–f). In CM all three types of cells pro-
liferated during the whole study independently from the 
presence or absence of BMP-2. However, when supple-
menting CM with BMP-2, the rate of cell growth was 
decreased in a concentration dependent manner. The same 
Fig. 4  Visualization by Alizarin Red staining (a) and quantification 
of calcium deposition (b), as well as alkaline phosphatase activity 
(c) of DPSC cells at the 6th, 12th and 18th days of differentiation. 
Error bars represent standard deviation calculated from three paral-
lel measurements. Statistical analysis was performed using ANOVA 
followed by Bonferroni statistical test. P < 0.05 or P < 0.005 values 
were labeled on the figure as “*” and “**”, respectively
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phenomenon was observed in OIM, except for Saos-2. In 
OIM the proliferation of Saos-2 cells stopped at day 4, 
thereafter the number of cells (as determined with alamar 
blue assay) decreased over time at day 6 and 8., This is in 
line with findings of others [14].
Investigating the components of the OIM, we found that 
only β-GLY had an effect on all the three cell lines decreas-
ing cell growth. DEX alone had inhibitory effect but only 
on DPSC cells (Fig. 2a–c). Moreover, a synergistic effect 
could be observed between β-GLY and BMP-2 in the case of 
Saos-2 and HEPM (Fig. 2d, e). The combination of BMP-2 
with β-GLY or with DEX did not result in such interaction 
in DPSCs (Fig. 2f).
BMP‑2 increases mineralization and alkaline 
phosphatase activity in a cell type and molecular 
environment dependent manner
Mineralization was measured in CM, OIM and CM sup-
plemented with β-GLY after 6 days of incubation. From the 
components of the OIM medium, only β-GLY was investi-
gated since it was the only agent that showed similar effect 
on all cell types in the proliferation assays. After 6 days, 
staining could be seen in Alizarin Red stained DPSC cells 
cultured in OIM, but it could not be quantified by spec-
trofluorimetry. The alkaline phosphatase activity did not 
change either compared to control cells grown in CM. A 
significant increase could be observed in the mineralization 
when OIM was supplemented with BMP-2 which was veri-
fied by quantitative measurement (Fig. 3a, b) as well. In par-
allel with Ca deposition, an increased alkaline phosphatase 
activity was also measured (Fig. 3c). In the case of Saos-2 
cells significant calcium deposition could be observed not 
only in OIM, but also in β-GLY (Fig. 3d, e). The alkaline 
phosphatase activity correlated well with the level of min-
eralization (Fig. 3f). When combining BMP-2 with OIM 
or with β-GLY, synergistic effects were observed with both 
media (Fig. 3d–f). In contrast to DPSC and Saos-2 cultures, 
neither mineralization, nor increased alkaline phosphatase 
activity were detected in HEPM cells (Fig. 3g–i).
Fig. 5  Expression level of Runx2 (a) and BMP-2 (b) genes were 
quantitatively analyzed in Saos-2 cells cultured for 4 days at different 
conditions found to enhance mineralization and alkaline phosphatase 
activity. Runx2 (c) and BMP-2 (d) gene expression analysis were per-
formed at the 6th, 12th and 18th days of differentiation in DPSCs. 
Error bars represent standard deviation calculated from three paral-
lel measurements. Statistical analysis was performed using ANOVA 
followed by Bonferroni statistical test. P < 0.05 or P < 0.005 values 
were labeled on the figure as “*” and “**”, respectively
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The differentiation was followed not only for 6 days, but 
also for 12 and 18 days. This longer study could not be per-
formed on Saos-2 cells cultured in OIM since after the 6th 
day the number of live cells decreased (Fig. 1e). Thus, at 
day 8 not enough cell lysates could be collected to perform 
accurate measurements. In contrast to Saos-2, DPSC and 
HEPM cells could be cultured and differentiated for more 
than 6 days. In DPSC cells cultured in OIM independently of 
the presence or absence of BMP-2, no further mineralization 
was measured and alkaline phosphatase activity seemed to 
be decreased at day 12 compared to day 6. However, this dif-
ference was not statistically significant. When supplement-
ing OIM medium with BMP-2, a synergistic effect could be 
detected. The effect of OIM medium was more pronounced 
when the differentiation was performed for 18 days and the 
synergistic effect between BMP-2 and OIM still existed 
(Fig. 4a–c). Longer differentiation was also performed on 
HEPM cells where no detectable changes were observed 
(data not shown).
BMP‑2 upregulates osteogenic marker genes 
in a cell type and molecular environment dependent 
manner
The expression levels of early marker genes Runx2 and 
BMP-2 was investigated using reverse transcription quan-
titative real-time PCR. In these experiments we only used 
those treatments which were found to enhance mineraliza-
tion and increase alkaline phosphatase activity. Saos-2 cells 
were grown for 4 days in CM, OIM or β-GLY media in the 
presence or absence of BMP-2. For gene expression analysis 
4-day long differentiation was selected according to pub-
lished data [14]. In the case of Saos-2 the expression level 
of Runx2 did not change at day four in response to any of 
the treatments. However, the level of endogenous BMP-2 
significantly increased in cells treated with β-GLY and mod-
erately increased in OIM. BMP-2 had synergistic effects in 
both cases (Fig. 5a, b).
DPSC cells could be differentiated longer than Saos-2. 
Therefore, gene expression levels could be analyzed at the 
6th, 12th and 18th days of differentiation, which were the 
same time points as in mineralization and alkaline phos-
phatase activity measurements. Cells were grown in CM, 
OIM, CM  +  BMP-2 and OIM  +  BMP-2. At day 6 the 
expression level of Runx2 was the highest as a result of 
OIM + BMP-2 treatment and it was statistically significant 
compared to cells in CM. Moderate and minor, statistically 
not significant increases of expression level were measured 
in OIM in CM + BMP-2, respectively. From day 6, Runx2 
expression gradually decreased over time as detected at 
days 12 and 18 (Fig. 5c). In contrast, the expression level 
of BMP-2 gradually increased over time from day 6 to 
day 18 in response to OIM + BMP-2 (Fig. 5d), showing 
reverse correlation with Runx2. In OIM and CM + BMP-2 
no changes were detected in BMP-2 expression compared 
to control CM.
Discussion
BMP-2 is known to enhance osteogenic differentiation. 
However, treating cells with BMP-2 alone may result in vari-
ous outcomes depending on the cell type and the osteoinduc-
tive molecules (molecular environment) [15–17].
In the present study BMP-2 was examined alone or in 
combination with different compounds known to initiate 
osteogenic differentiation involving different cell types, 
namely DPSC, Saos-2 and HEPM. BMP-2 inhibited the 
proliferation of all the three cell types in a concentration 
dependent manner both alone, in CM and in combination 
with a mixture of osteoinductive agents. OIM is known to 
initiate osteogenic differentiation and is commonly used 
in such experiments. Investigating the contribution of its 
components to osteogenic differentiation we found that only 
β-GLY inhibited cell proliferation in all three cell types. 
When cells were treated with BMP-2 in combination with 
β-GLY, synergistic effects were found on the inhibition of 
proliferation in HEPM and Saos-2 cells. According to pub-
lished data, the decreased proliferation rate may be related 
to the differentiation process [8, 18–20].
Further investigating its osteogenic differentiation effect, 
BMP-2 alone had no effect on alkaline phosphatase activ-
ity. However, when combining BMP-2 with β-GLY or with 
OIM medium, synergistic effects could be detected in Saos-2 
cells. An increased level of alkaline phosphatase activity was 
also measured in DPSCs as a result of a synergistic effect, 
but only when BMP-2 was combined with OIM. β-GLY is 
the substrate of the alkaline phosphatase enzyme known 
to have increased activity in mature osteoblasts [21–23]. 
Hydrolysis of β-GLY results in the extracellular accumu-
lation of inorganic phosphate that can react spontaneously 
with the  Ca2+ ions of the culture medium forming solid crys-
tals which precipitate in the extracellular matrix [22–24]. In 
our differentiation experiments when increased ALP activity 
was detected, the amount of deposited crystals showed posi-
tive correlation with ALP in line with expectations.
When studying osteogenic marker genes, OIM 
increased the expression of Runx2 which was further 
increased by BMP-2 in DPSCs differentiated for 6 days. 
From the components of OIM, DEX, AA and β-GLY can 
increase Runx2 expression through signaling pathways 
involving TAZ, MKP-1 and FHL-2 proteins or phospho-
rylation of ERK1/2. [25]. When differentiating DPSCs for 
more than 6 days, Runx2 level decreased gradually over 
time as the maturation progressed which is in line with 
published data [26]. While Runx2 expression is low in 
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committed osteoprogenitors, it becomes elevated during 
differentiation in preosteoblasts and immature osteoblasts, 
then it decreases again in mature osteoblast and osteocytes 
[27, 28].
In Saos-2 cells, differentiation appears to be terminated 
earlier, than in DPSCs as suggested by our proliferation 
measurements and also by published data [14]. Since no 
differences in Runx2 expression could be detected between 
control and differentiated samples, it can be hypothesized 
that the mRNA level of Runx2 has already decreased at day 
four as a consequence of the shorter differentiation time. 
According to recently published data, another explanation 
also arises. In Saos-2 cells, p53 tumor suppressor, which 
indirectly inhibits Runx2 expression through micro RNA-34, 
is downregulated. Thus, decreased level of p53 may result in 
elevated level of Runx2 [29]. Therefore, high Runx2 expres-
sion may not be increased further in Saos-2 cells exposed to 
osteogenic stimuli.
The expression level of endogenous BMP-2 correlated 
well with the increased activity of the alkaline phosphatase 
enzyme. This can be explained by the increased concentra-
tion of extracellular inorganic phosphate known to be able 
to enter into the cell via phosphate transporters [24]. In turn 
inorganic phosphate can trigger signaling through ERK and 
cAMP/protein kinase and activation of these signaling path-
ways increases the expression of BMP-2 [25]. This is in 
line with the increasing level of endogenous BMP-2 both in 
DPSC and Saos-2 cells.
Based on our results it can be concluded that BMP-2 
alone is not a sufficient signal to induce the maturation of 
osteoblast progenitors examined. However, in an appropri-
ate molecular environment permissive for osteogenic dif-
ferentiation, containing molecules such as β-GLY, BMP-2 
can act in a synergistic manner in the case of DPSC and 
Saos-2 cells.
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